GENMAB A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,775.00 DKK | -0.08% |
|
-4.29% | -17.63% |
EPS & Dividend: Genmab A/S
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 34.03 | 72.21 | 45.54 | 83.65 | 66.02 | 82.51 | 94.09 | 120.2 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 1,481.50 | 2,463.00 | 2,630.00 | 2,941.00 | 2,155.00 | 1,775.00 | 1,775.00 | 1,775.00 |
| Nbr of stocks (in thousands) | 65,075 | 65,410 | 65,423 | 65,362 | 65,322 | 63,506 | - | - |
| Announcement Date | 19/02/20 | 23/02/21 | 16/02/22 | 22/02/23 | 14/02/24 | - | - | - |
1DKK in Million2DKK
Estimates
Upcoming events: Genmab A/S
More events
| Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | 21.53x | 3.399 | 4.24x | ||
| -.--% | -.--% | -246.97x | 7.695 | 10.83x | ||
| -.--% | -.--% | 30.95x | 4.258 | 8.14x | ||
| -.--% | -.--% | -527.02x | 7.369 | 14.5x | ||
| -.--% | -.--% | -46.31x | 1.354 | 5.15x | ||
| - | - | - | - | - | ||
| -.--% | -.--% | -32.26x | 6.266 | 5.3x | ||
| +2.42% | +2.64% | 12.13x | 1.883 | 2.65x | ||
| -.--% | -.--% | -25.49x | - | - | ||
| -.--% | -.--% | -14.09x | -57.174300 | 36.79x | ||
| Average | +0.27% | +0.29% | -91.95x | -3.12 | 10.95x | |
| Weighted average by Cap. | +0.10% | +0.11% | -118.05x | 3.38 | 9.74x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Estimates Revisions:
More analyst reviews
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition